Business Segments12 metrics
RevenueImdusiran IM-PROVE I, II & III clinical trials expenseAB-101-001 Phase 1a/1b clinical trial expenseOther early research and development programs expenseG&ARestructuring costsOther segment expenseInterest IncomeNet Income (Loss)Consolidated net lossGain on sale of property and equipmentSegment Reporting Information, Profit (Loss)